Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Edit Your Profile
Pathogenic mutation in VPS35 impairs its protection against MPP
+
cytotoxicity
Article
Bi, F, Li, F, Huang, C
et al
. (2013). Pathogenic mutation in VPS35 impairs its protection against MPP
+
cytotoxicity .
9(2), 149-155. 10.7150/ijbs.5617
Share this citation
Twitter
Email
Bi, F, Li, F, Huang, C
et al
. (2013). Pathogenic mutation in VPS35 impairs its protection against MPP
+
cytotoxicity .
9(2), 149-155. 10.7150/ijbs.5617
Copy Citation
Share
Overview
Identifiers
Additional Document Info
View All
Overview
cited authors
Bi, F; Li, F; Huang, C; Zhou, H
authors
Zhou, Hongxia
abstract
Parkinson's disease primarily results from progressive degeneration of dopaminergic neurons in the substantia nigra. Both neuronal toxicants and genetic factors are suggested to be involved in the disease pathogenesis. The mitochondrial toxicant 1-methyl-4-phenylpyridinium (MPP+) shows a highly selective toxicity to dopaminergic neurons. Recent studies indicate that mutation in the vacuolar protein sorting 35 (vps35) gene segregates with Parkinson's disease in some families, but how mutation in the vps35 gene causes dopaminergic cell death is not known. Here, we report that enhanced VPS35 expression protected dopaminergic cells against MPP+ toxicity and that this neuroprotection was compromised by pathogenic mutation in the gene. A loss of neuroprotective functions contributes to the pathogenesis of VPS35 mutation in Parkinson's disease. © Ivyspring International Publisher.
publication date
January 26, 2013
Identifiers
Digital Object Identifier (DOI)
https://doi.org/10.7150/ijbs.5617
Additional Document Info
start page
149
end page
155
volume
9
issue
2
Mentioned by
1
peer review sites
36
readers on Mendeley
1
readers on CiteULike
See more details